Evaluation of the Effectiveness, Safety, and Cost of a Smart Home-based Hospital System for Patients With Interstitial Lung Disease: Prospective Multicenter Randomized Controlled Trial

NARecruitingINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

September 6, 2024

Primary Completion Date

May 2, 2026

Study Completion Date

May 2, 2026

Conditions
Interstitial Lung Disease
Interventions
BEHAVIORAL

Immediate application of the Smart Homespital system

The Smart Homespital system can be applied for the first 3 months (12 weeks), and then the primary and secondary variables will be evaluated at 3, 6, 9months. While applying the Smart Homespital system, exercise three times a week, measure sleep twice a week, and questionnaire assessments (mMRC, CRQ, EQ-5D, K-CESD) are conducted once every two weeks.

BEHAVIORAL

Delayed application of the Smart Homespital system after 3 months

The waiting list-control group will receive general medical services for the first 3 months and will receive a Smart Homespital system for 3-6 months. Primary and secondary variables will be monitored between 3, 6, and 9 months. While applying the Smart Homespital system, exercise three times a week, measure sleep twice a week, and questionnaire assessments (mMRC, CRQ, EQ-5D, K-CESD) are conducted once every two weeks.

Trial Locations (1)

03722

RECRUITING

Division of Pulmonary and Critical Care Medicine, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER